论文部分内容阅读
阿糖胞苷(Ara-c)被认为是治疗急性白血病和非何杰金氏淋巴瘤最主要的药物之一,故须知用该药治疗病人可能发生的并发症。 作者回顾分析1982～1987年间用包括Ara-c
Cytarabine (Ara-c) is considered as one of the most important drugs for the treatment of acute leukemias and non-Hodgkin’s lymphoma. Therefore, it should be noted that the drug may be used to treat patients’ possible complications. The authors reviewed and analyzed between 1982 and 1987 the inclusion of Ara-c